Shares of Danaher Co. (NYSE:DHR – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the twenty-one analysts that are covering the stock, Marketbeat.com reports. Five research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $284.14.
A number of research firms recently weighed in on DHR. JPMorgan Chase & Co. decreased their target price on Danaher from $310.00 to $300.00 and set an “overweight” rating on the stock in a research report on Tuesday. StockNews.com cut Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, December 14th. KeyCorp lifted their price target on shares of Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 23rd. Raymond James dropped their price objective on shares of Danaher from $300.00 to $275.00 and set an “outperform” rating for the company in a research note on Tuesday, January 21st. Finally, Guggenheim began coverage on shares of Danaher in a research note on Thursday, December 19th. They issued a “buy” rating and a $275.00 target price on the stock.
Check Out Our Latest Stock Report on DHR
Institutional Inflows and Outflows
Danaher Price Performance
NYSE DHR opened at $223.12 on Thursday. The stock has a 50-day simple moving average of $236.09 and a 200 day simple moving average of $253.66. Danaher has a twelve month low of $223.00 and a twelve month high of $281.70. The stock has a market capitalization of $161.15 billion, a PE ratio of 42.58, a P/E/G ratio of 4.43 and a beta of 0.83. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37.
Danaher (NYSE:DHR – Get Free Report) last announced its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting the consensus estimate of $2.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. During the same period in the prior year, the business earned $2.09 EPS. Research analysts anticipate that Danaher will post 7.5 EPS for the current year.
Danaher Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Friday, December 27th will be paid a dividend of $0.27 per share. The ex-dividend date of this dividend is Friday, December 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.48%. Danaher’s dividend payout ratio (DPR) is currently 20.61%.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Further Reading
- Five stocks we like better than Danaher
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- Why Are These Companies Considered Blue Chips?
- 3 Steel Stocks Soaring After Tariff Announcements
- Short Selling – The Pros and Cons
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.